- Home
- CPRX vs MYRG Comparison
CPRX vs MYRG Comparison
Compare CPRX & MYRG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CPRX | MYRG |
|---|---|---|
| Founded | 2002 | 1891 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Water Sewer Pipeline Comm & Power Line Construction |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.4B | 3.9B |
| IPO Year | 2006 | 2008 |
Fundamental Metrics
Financial Performance| Metric | CPRX | MYRG |
|---|---|---|
| Price | $31.17 | $435.57 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 8 |
| Target Price | $35.00 | ★ $262.43 |
| AVG Volume (30 Days) | ★ 2.3M | 285.6K |
| Earning Date | 05-11-2026 | 04-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 28.24 | ★ 311.48 |
| EPS | 1.68 | ★ 2.99 |
| Revenue | $119,072,803.00 | ★ $1,531,169,000.00 |
| Revenue This Year | $9.20 | $11.87 |
| Revenue Next Year | $10.51 | $8.48 |
| P/E Ratio | ★ $18.54 | $142.01 |
| Revenue Growth | ★ 16.39 | N/A |
| 52 Week Low | $19.05 | $154.55 |
| 52 Week High | $32.56 | $475.40 |
Technical Indicators
Market Signals| Indicator | CPRX | MYRG |
|---|---|---|
| Relative Strength Index (RSI) | 73.25 | 70.66 |
| Support Level | $22.41 | $184.77 |
| Resistance Level | $32.56 | N/A |
| Average True Range (ATR) | 1.30 | 19.50 |
| MACD | 0.30 | 7.76 |
| Stochastic Oscillator | 80.10 | 73.46 |
Price Performance
Historical ComparisonAbout CPRX Catalyst Pharmaceuticals Inc.
Catalyst Pharmaceuticals Inc is a commercial-stage, patient-centric biopharmaceutical company focused on in-licensing, developing, and commercializing novel high-quality medicines for patients living with rare and difficult to treat diseases. The Company sells three commercial stage drug products, FIRDAPSE (amifampridine), AGAMREE (vamorolone), and FYCOMPA (perampanel). The Company is currently seeking to further expand its product portfolio, with a focus on acquiring the rights to immediately and near-term accretive assets to treat rare (orphan) diseases across therapeutic areas, including clinical-stage opportunities with established proof of concept.
About MYRG MYR Group Inc.
MYR Group Inc is a U.S.-based holding company that provides specialty electrical construction services through its subsidiaries. The company operates through two segments. The transmission and distribution segment provides designing, engineering, procurement, construction, upgrade, maintenance, and repair services on transmission and distribution networks and substation facilities. The commercial and industrial segment provides services such as the design, installation, maintenance, and repair of commercial and industrial wiring, installation of traffic networks, and the installation of bridges. MYR Group generates the majority of its sales from the United States and Canada.